75% of US-Based Operation Warp Speed Vaccine Trials Overseen by Advarra IRB, IBC
Webinar: October 27
Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.
Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.
Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more
Our Latest Updates
Discover What’s Happening at Advarra
Advarra IRB Chair Luke Gelinas Featured in PRIM&R Blog and Webinar About Complexity in Clinical Trial Design
In June, Advarra IRB Chairperson Luke Gelinas was a guest speaker in a PRIM&R webinar called Complexity in Clinical Trial Design: A Primer on Adaptive and Platform Trials. As a…
Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
COVID-19 has focused the importance of diversity, equity, and inclusion considerations in clinical trial enrollment. How can the research community address the root causes for lack of diversity? What actions…
Is GDPR Coming to the US? CCPA and Its Impact on Research
Remember on the older The Price Is Right game shows with Bob Barker, when the announcer would describe to the contestant they could win “a brand-new car!” and then proceed…
Society of Research Administrators International (SRA International) Annual Meeting
October 17-22, 2020
Virtual